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                    Final Examination  
 
 
PHA311 – Clinical Biochemistry 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has A and B sections  
 
Section A: Suggested Time: 90 minutes  
Answer ALL 7 questions on the booklet provided. Marks: 50  
 
Section B: Suggested Time: 90 minutes  
Answer ALL 4 questions in the booklet provided. Marks: 50 
 
Note that questions ARE NOT of equal value. 
Read ALL questions carefully.  
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 20 Page Book 
1 x Scrap Paper 
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Student Number       
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Section A 
Short Essay Questions 
Total Number of Marks for this section: 50 Marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section A: 90 minutes 
Question 1  
A) Discuss the different safety hazards are routinely experienced by clinical laboratory personal. 
 
B) Briefly outline the biological safety, chemical safety, radiation safety and fire safety in current clinical 
laboratory practice. 
  
(2x4= 8 Marks) 
 
Question 2  
A) Discuss the potential advantages and disadvantages of POCT.  
(4 Marks) 
B) What are the differences between total calcium, corrected calcium and ionised calcium in blood 
calcium test? 
 (4 Marks) 
(Total: 8 Marks) 
 
Question 3  
Discuss any TWO (2) of the following clinical abnormalities.  
I. Causes and classification of hyponatremia by osmolality 
II. Consequences and interpretation of hypernatremia 
III. Mechanism and evaluation of hypokalaemia 
(4+4= 8 Marks) 
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Question 4  
Regarding diagnosis of diabetes mellitus or its complications, write short notes on ANY FOUR (4) of the 
following: 
I. Typical diabetes ketoacidosis (DKA) 
II. Oral Glucose Tolerance Test (OGTT) 
III. Hyperosmotic non-ketonic coma (HONKC 
IV. BSL tests 
V. Diabetic retinopathy 




A) For mechanisms and response in respiratory acidosis and alkalosis, draw a chart to show the 
physiological response for hypoventilation and hyperventilation. 
(3 Marks) 
B) Briefly discuss the compensatory mechanisms through negative feedback and change in renal 
reabsorption? 
(3 Marks) 
(Total: 6 Marks) 
 
Question 6  
Regarding a routine Full Blood Examination (FBE) report, discuss the importance of following 
parameters. Give TWO (2) clinical examples for an abnormal count/reading for each. 
I. Mean Cell Diameter(MCD) 
II. Mean Corpuscular Haemoglobin Concentration (MCHC) 
III. Reticulocyte count 
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Question 7  
A) What does it mean by positive troponin level? 
(2 Marks) 
B) List out the current cardiac marker tests are utilised in clinical practice. Where do these markers 
originate from, and why are they useful in clinical practice? 
(4 Marks) 
(Total: 6 Marks) 
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Case Study Based Questions 
Total Number of Marks for this section: 50 Marks 
This section should be answered in the Answer Booklet provided. 
Marks for each question are indicated. 
Suggested Time allocation for Section B: 90 minutes 
 
Case study 1 
A 58-year-old man with a history of alcoholism complained of increased skin fragility and lesions on his 
hands, forehead, neck, ears on exposure to the sun. Also noted on physical examination were 
hyperpigmentation and hypertrichosis. Lab findings showed an increase in urinary uroporphyrin and 
slight increase in coproporphyrin, with normal levels of aminolevulinic acid (ALA) and porphyrinogen. 
Isocoporphyrin was elevated in the faeces. Serum ferritin and transaminase were increased. RBC ZPP 
and FEB were normal. 
 
Questions: 
1. What is the probable disorder? (3 Marks) 
 
2. What confirmatory test should be done? (3 Marks) 
 
3. What are the other causes of acquired cases of this type? (4 Marks) 
 
4. How is this type differentiated from other porphyria's causing cutaneous symptoms? (5 Marks) 
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Case study 2 
Mr John is a 60-year-old Darwin man, who presents to the ED with repeated episodes of yellow skin 
discolouration, on a background of drinking a carton of beer per day. On examination, the man has lots 
of bruising on his arms as well as a swollen belly and swollen legs. The doctor also orders a full blood 
examination (FBE) and liver function tests (LFT), the results are as follow: 
FBE 
• Hb 100 130-180 g/L 
• RCC 3.2 4.5-6.5 x10^12/ L 
• Hct 34 40-54% 
• MCV 106 80-100 fL 
• Plt 163 150-400x10^9/ L 
• WCC 12.1 5.0-10.0x10^9/ L 
• Neutrophil 8.9 2.0-7.5x10^9/ L 
LFT 
• Albumin  15 (L) 32-45 g/L 
• Bilirubin (total)  40 (H) <20 micromol/L 
• Bilirubin (conjugated)  36 (H) <4.0 micromol/L 
• ALP  30 25-100 U/L 
• GGT  100(H) <50 U/L 
• ALT  35 <30 U/L 
• AST  35 <40 U/L 
Questions 
1. What is the patient status according to these tests? (3 Marks) 
2. Why are albumin and some FBE levels low? (4 Marks) 
3. What would you expect on the FBE based on the clinical examination? (4 Marks) 
4. What other test would you like to complement/confirm the previous finding? What findings will you 
expect? (4 Marks) 
(Total: 15 Marks) 
Case study 3 
A 60-year man entered Emergency Department after 2 days of “not feeling so well”. History revealed 
that a myocardial infraction 5 years ago, when he was prescribed digoxin. Two years ago, he was 
prescribed a diuretic after periodic bouts of oedema. An Electrocardiogram (ECG) at time of admission 
indicated a cardiac arrhythmia.  
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Digoxin: 1.4 ng/ml, therapeutic 0.5-2.2 
Na =137 mmol/L 
K =2.5 mmol/L 
Cl =100 mmol/L 
HCO3 =25 mmol/L 
Mg =0.4 mmol/L 
Ca =1.0 mmol/L (ionised) 
 
Questions: 
1. What may be the cause for arrhythmia? (2 Marks) 
2. What is the most likely cause for the hypomagnesemia? (2 Marks) 
3. What is the most likely cause for decreased K and ionized Ca levels? (3 Marks) 
4. What type of treatment would be helpful? (4 Marks) 
 (Total: 11 Marks) 
Case study 4 
Louise, an 86-year-old patient with hypertension is brought to the emergency department at Royal 
Darwin Hospital based in Tiwi. She has had gastroenteritis for 3 days and has become increasingly weak 
and confused. Her daughter states that her mum takes a “strong water tablet”. Her blood pressure is 
found to be low. Her weight is 66.5 kg. Her medical records from a week ago state her weight as 70kg.  
Questions: 
1. How, many liters of fluid loss does the weight loss represent, and what is the percentage weight 
loss? (2 Marks) 
 
2. What is the mechanism of action of diuretics (briefly) and which class is the most potent?  
(4 Marks) 
 
3. Explain the compensatory mechanisms that were triggered in this patient. (3 Marks) 
 
(Total: 9 Marks) 
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END OF EXAM 
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Reference ranges for regular lab tests  
Urea and electrolytes (U&E)  
Na+ 135.0-145.0 mmol/L  
K+ 3.50-4.50 mmol/L (plasma) 3.8-4.9 mmol/L (serum)  
Cl- 95-110 mmol/L  
Urea 3.8-8.0 mmol/L  
Creatinine 60-100 µmol/L  
eGFR > 90 mL/min/1.73 m2  
Osmolality (serum) 275-295 mOsm/kg  
Anion gap 13-17 mEq/L  
 
Calcium, magnesium and phosphate (CMP)  
Ca2+ (total) 2.1-2.6 mmol/L  
Ca2+ (ionised) 1.16-1.3 mmol/L  
PO43- 0.8-1.5 mmol/L  
Mg2+ 0.8-1.0 mmol/L  
 
Arterial blood gas (ABG)  
pH 7.35-7.45  
pO2 80-110 mmHg  
pCO2 35-45 mmHg  
Bicarbonate (HCO3-) 22-33 mmol/L  
 
Full blood examination (FBE)  
Hb 140-174 (male); 120-160 (female) g/L  
RCC 4.50-5.50 (male); 4.0-5.0 (female) x1012 /L  
Haematocrit 0.42-0.52 or 42-52 % (male); 0.36-0.48 or 36-48% (female)  
MCV 80.0-100.0 fL  
RDW 11.5-14.5 %  
Platelets 150-450 (x109 /L)  
WCC 4.0-11.0 (x109 /L)  
Neutrophil 40-80%; or 2.0-7.5 (x109 /L)  
Lymphocytes 20-40%; or 1.5-4.0 (x109 /L)  
Monocytes 2-10%; or 0.2-0.8 (x109 /L)  
Eosinophils 1-6%; or 0.0-0.4 (x109 /L)  
Basophils <2%; or 0.0-0.1 (x109 /L) 
 
Liver function test (LFT)  
 Semester 1, 2019 FINAL EXAMINATION Page 11 of 11  
PHA311 – Clinical Biochemistry 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 
CIRCUMSTANCE.  THIS EXAMINATION IS PRINTED DOUBLE-SIDED. 
 
ALT <30 U/L  
AST <40 U/L  
ALP 30-100 U/L  
GGT <30 U/L (female); <50 U/L (male)  
Bilirubin (total) <20 micromol/L  
Bilirubin 
(conjugated) 
<4.0 micromol/L  
Albumin 32-45 g/L  
Total protein 63-80 g/L  
Pancreatic lipase 8 – 78 U/L  
 
Thyroid function test (TFT)  
TSH 0.4-5.0 mU/L  
T4 (free) 10-25 pmol/L  
T3 (free) 3.0-6.5 pmol/L  
 
Carbohydrate metabolism  
BSL (random) 3.0-7.7 mmol/L  
BSL (fasting) 3.0-5.5 mmol/L  
HbA1c (non-DM)  4.3-5.7% (NGSP); 23-39 mmol/mol (IFCC)  
HbA1c (DM) 
therapeutic target 
<7% *  
 
Fasting lipid biochemistry  
Total cholesterol  <5.5 mmol/L  
LDL 2-3.4 mmol/L  
HDL  >1 mmol/L  
Non-HDL cholesterol  <2.5 mmol/L  
TG  <1.7 mmol/L  
 
Others  
Troponin T  <0.01 μg/L  
CRP <3 mg/L  
D-dimer <500 μg/L  
BNP <20 nmol/L 
 
